In this issue:
COMPARE-PsA: Front-line methotrexate/leflunomide superior to methotrexate
CONTROL demonstrates efficacy of methotrexate/adalimumab
High prevalence of pregnancy complications in women with axSpA
Fertility and pregnancy outcomes in women with SpA
Depression is prevalent in PsA and correlates with disease activity
Longer diagnostic delay of axSpA in patients with fibromyalgia or disc disease
Factors associated with remission in recent-onset axSpA
Lower risk of MACE with anti-TNF versus anti-IL-12/23 or IL-17 biologics
Disease activity outcome measures are not commonly recorded in EMRs
Sociodemographic determinants in the evolution of pain in inflammatory rheumatic diseases
Please login below to download this issue (PDF)